Will Agomab Therapeutics NV's market cap be less than $600M at market close on IPO day?
⏸ Signals below are frozen at the last trade before this market resolved — they are not live.
YesY-NNo
Position$66−$834$900
Holders22+1012
Trades71+3833
YesΔ Y−NNo
Track record
Avg settle win rate47.5%
−6.9 pp
54.4% Cost basis
Median cost vs price×7.11
+6.18×
×0.93 Top-20 avg cost vs price×8.22
+7.29×
×0.92 Flow
Recent buyer dominance1.00
+0.00
1.00 Time-norm taker flow██
·
██ Position health
Unrealized PnL-87.8%
−96.0 pp
8.2% Underwater %82.7%
+82.7 pp
0.0% Crowd
New wallets %11.1%
−67.1 pp
78.2%